Analysts’ Weekly Ratings Updates for McKesson (MCK)

A number of firms have modified their ratings and price targets on shares of McKesson (NYSE: MCK) recently:

  • 11/18/2026 – McKesson had its price target raised by Barclays from $1,000.00 to $1,235.00. They now have an “overweight” rating on the stock.
  • 11/10/2026 – McKesson had its price target raised by JPMorgan Chase & Co. from $1,042.00 to $1,255.00. They now have an “overweight” rating on the stock.
  • 11/9/2026 – McKesson was upgraded by Weiss Ratings from “buy (b)” to “buy (b+)”.
  • 11/5/2026 – McKesson had its price target raised by UBS Group from $1,200.00 to $1,250.00. They now have a “buy” rating on the stock.
  • 11/5/2026 – McKesson had its price target raised by TD Cowen from $1,006.00 to $1,200.00. They now have a “buy” rating on the stock.
  • 11/5/2026 – McKesson had its price target raised by Leerink Partners from $1,070.00 to $1,200.00. They now have an “outperform” rating on the stock.
  • 11/5/2026 – McKesson had its price target raised by Royal Bank Of Canada from $845.00 to $965.00. They now have a “sector perform” rating on the stock.
  • 10/20/2026 – McKesson had its price target raised by Mizuho from $905.00 to $1,020.00. They now have a “neutral” rating on the stock.
  • 10/17/2026 – McKesson was upgraded by Wall Street Zen from “hold” to “buy”.
  • 10/16/2026 – McKesson had its price target raised by UBS Group from $1,080.00 to $1,200.00. They now have a “buy” rating on the stock.
  • 10/7/2026 – McKesson had its price target raised by Leerink Partners from $1,030.00 to $1,070.00. They now have an “outperform” rating on the stock.
  • 10/6/2026 – McKesson was given a new $977.00 price target by Morgan Stanley.

McKesson Stock Down 2.0%

Shares of NYSE MCK traded down $21.81 during midday trading on Thursday, reaching $1,062.62. 611,109 shares of the company were exchanged, compared to its average volume of 907,378. The stock’s 50-day moving average price is $967.25 and its 200-day moving average price is $878.54. The stock has a market cap of $122.69 billion, a P/E ratio of 27.32, a PEG ratio of 1.85 and a beta of 0.27. McKesson Corporation has a one year low of $723.68 and a one year high of $1,121.50.

McKesson (NYSE:MCK – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $11.68 EPS for the quarter, beating analysts’ consensus estimates of $10.72 by $0.96. The company had revenue of $110.96 billion during the quarter, compared to analysts’ expectations of $109.90 billion. McKesson had a negative return on equity of 202.94% and a net margin of 1.12%. McKesson’s revenue was up 7.5% compared to the same quarter last year. During the same period in the prior year, the company earned $9.86 EPS. On average, equities research analysts anticipate that McKesson Corporation will post 46.09 EPS for the current year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Tuesday, December 1st will be paid a dividend of $0.94 per share. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Tuesday, December 1st. McKesson’s dividend payout ratio (DPR) is presently 9.67%.

Insider Activity

In other news, CAO B Jr sold 111 shares of the company’s stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $891.45, for a total value of $98,950.95. Following the completion of the transaction, the chief accounting officer owned 521 shares of the company’s stock, valued at $464,445.45. This represents a 17.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Francisco Fraga sold 650 shares of the company’s stock in a transaction that occurred on Thursday, November 5th. The shares were sold at an average price of $1,102.96, for a total value of $716,924.00. Following the completion of the transaction, the executive vice president directly owned 4,414 shares of the company’s stock, valued at $4,868,465.44. This represents a 12.84% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 2,161 shares of company stock worth $2,242,515. Company insiders own 0.06% of the company’s stock.

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.

Read More

Receive News & Ratings for McKesson Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson Corporation and related companies with MarketBeat.com's FREE daily email newsletter.